SABLICH KIM (Chief Commercial Officer) sold 1.3% of their position (785.00 shares) of MYOVANT SCIENCES LTD. on the open market
Open‑market sale worth $5.8K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 3/19/2020ACC: 0001209191-20-020279
Officer· Chief Commercial Officer
Since Dec 2018
-785.00
Net shares
Net seller
$5.8K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
785.00 disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−770.00
Price / share
$7.38
Trade value
$5.68K
% of position
1.3%
3/18/2020
59.69K→58.92K
Common Stock
Direct
Shares
−15.00
Price / share
$6.93
Trade value
$103.95
% of position
0.0%
3/18/2020
58.92K→58.91K
Total
Net shares
−785.00
Net value
-$5.79K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/18/2020 | S · Sale | −770.00 | $7.38 | $5.68K | 1.3% | 59.69K | 58.92K |
| Common Stock Direct | 3/18/2020 | S · Sale | −15.00 | $6.93 | $103.95 | 0.0% | 58.92K | 58.91K |
| Total | −785.00 | -$5.79K | ||||||
Derivative Transactions0
No derivative transactions reported